Fang Wang

Dr. Fang Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
LWLiangfeng Wang
Liangfeng Wang
FWFang Wang
Fang Wang
XZXiaofei Zhang
Xiaofei Zhang
QCQingyao Chen
Qingyao Chen
JXJie Xu
Jie Xu
MYMing Yang
Ming Yang
Background. The Citrus aurantium‐ (ZhiShi, ZS‐) Rhizoma Atractylodis Macrocephalae (BaiZhu, BZ) pairs are often found in herbal formulas for constipation. The volatile oils of ZS and BZ (ZBVO) have good pharmacological activity against constipation, but the mechanism for treatment of slow transit constipation (STC) remains unclear. Method. A rat model using diphenoxylate tablets was constructed to investigate if transdermal administration of ZBVO would mediate intestinal microorganisms and fecal metabolites and improve STC symptoms. The regulatory effects of ZBVO at 0.15, 0.30, and 0.60 mL kg-1 d-1 on STC rats were assessed by measuring fecal water content, intestinal propulsion rate, histopathology, expression of gastrointestinal hormones, brain and intestinal peptides, and inflammatory factors. The changes in intestinal flora of STC rats were analyzed by 16S rRNA gene sequencing. Moreover, the untargeted fecal metabolomics analysis was performed by ultraperformance liquid chromatography quadrupole time‐of‐flight mass spectrometer (UPLC‐Q‐TOF‐MS) technology. Results. The results showed that ZBVO had a modulating effect on STC by increasing the fecal water content and intestinal propulsion rate. Transdermal administration of ZBVO decreased serum levels of interleukin 6 (IL‐6) and tumor necrosis factor‐α (TNF‐α) and increased the levels of gastrin (GAS) and substance P (SP). In addition, ZBVO increased 5‐hydroxytryptamine (5‐HT) levels and decreased vasoactive intestinal peptide (VIP) levels in colon and hippocampus tissues. The results of intestinal microbiota showed that ZBVO improved the diversity and abundance of intestinal microbiota and changed the community composition by decreasing Romboutsia and increasing Proteobacteria, Allobaculum, and Ruminococcaceae. And the feces metabolomics found that nicotinate and nicotinamide metabolism, purine metabolism, citrate cycle (TCA cycle), pyruvate metabolism, arachidonic acid metabolism, pyrimidine metabolism, and primary bile acid biosynthesis were modulated. Conclusion. These findings suggest that ZBVO can alleviate STC symptoms by promoting intestinal peristalsis, increasing fecal water content, regulating gastrointestinal hormone level, reducing the inflammatory response, and regulating brain and intestinal peptides after transdermal administration. And structural changes in the intestinal microbiota are closely related to host metabolism and intestinal microbiota destroyed in STC modeling could be significantly improved by the ZBVO, which provides a reference for the development of aromatic drug macrohealth products.

27 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
LMLi Mei
Li Mei
FWFang Wang
Fang Wang
MYMing Yang
Ming Yang
ZLZhiyong Liu
Zhiyong Liu
LWLiangfeng Wang
Liangfeng Wang
XZXiaofei Zhang
Xiaofei Zhang
Background. The Caoguo‐4 decoction, a classical Mongolian medicine formula, is widely used to treat spleen deficiency diarrhea (SDD) in Mongolian for decades. Previously, the Caoguo‐4 decoction volatile oil has been confirmed to be effective in ameliorating symptoms of spleen deficiency diarrhea in an animal model. However, the underlying mechanism of the Caoguo‐4 decoction volatile oil is yet to be established. The aim of the current study was to investigate the antidiarrheal effects and mechanism of the Caoguo‐4 decoction volatile oil. Method. Wistar rats were randomly divided into 5 groups of 10 animals including control, model, positive, Caoguo‐4 decoction, and Caoguo‐4 decoction volatile oil groups (10 rats in each group). All the rats, besides those in the control group, were induced to develop SDD by a bitter‐cold purgation method with Xiaochengqi decoction. The antidiarrheal effect of Caoguo‐4 decoction volatile oil was evaluated by pathological section, serum D‐xylose and AMS content, plasma MTL content, and gut microbiota analysis via 16S rRNA sequencing. Results. The results showed that the developed SDD rat model (model group) had decreased food intake, increased weight loss, soft stool, and bad hair color. When compared with the control group, serum was significantly reduced serum D‐xylose and AML but increased MTL levels in the model group (p < 0.05). However, after treatment with either the Caoguo‐4 decoction (the decoction group) or Smecta (the positive group) or volatile oil from the Caoguo‐4 decoction (the volatile oil group), a significant increase in the serum D‐xylose levels was observed. Additionally, AML levels significantly increased in the positive and volatile oil groups, and MTL levels significantly decreased in the decoction and volatile oil groups, when compared with the model group (p < 0.05). The pathological changes of the intestinal mucosa showed that the structure of the epithelium in the villi of the small intestine was affected, deformed, and incomplete in the model group when compared with the control group. However, either the decoction group or the volatile oil group recovered the villous morphology. The results of OTU analysis and alpha diversity analysis of intestinal bacteria showed that the intestinal microbiota of the SDD model rats showed an obvious decrease in richness and diversity of intestinal microbiota. But the intervention treatment of decoction and volatile oil could significantly recover the richness and diversity of intestinal microbiota. Conclusion. The intestinal microbiota destroyed in SDD modelling could be significantly improved by the Caoguo‐4 decoction volatile oils, which provides reference for clinical medication.